Aptose Biosciences Reports $2.99 GAAP Loss Per Share, Cash Drops to $4.1 Million
Aptose Biosciences holds $4.1 million in cash as of March 31, 2026, insufficient to fund operations without external advances. Aptose Biosciences Inc. posted a GAAP loss of $2.99 per share, reflecting ongoing financial strain. The company’s total cash and restricted cash s